Mounjaro® (tirzepatide)
- A prescription-only medicine administered as a once-weekly injection.
- Contains tirzepatide, which acts on GIP and GLP-1 receptors.
- May be prescribed only if a clinician decides it is suitable for you based on your medical history and current health.
- Commonly reported side effects include nausea, vomiting, diarrhoea, and decreased appetite.
- Always read the patient information leaflet carefully before use.